Scholars@Duke
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Development of bilateral acquired toxoplasmic retinochoroiditis during erlotinib therapy.

Publication ,  Journal Article
Rao, V; Schneider, E; Proia, AD; Fekrat, S
Published in: JAMA Ophthalmol
September 2014
Published version (DOI) Link to item

Duke Scholars

Alan David Proia
Author Alan David Proia Pathology
Sharon Fekrat
Author Sharon Fekrat Ophthalmology, Vitreoretinal Diseases & Surgery
Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA Ophthalmol

DOI

10.1001/jamaophthalmol.2014.1088

EISSN

2168-6173

Publication Date

September 2014

Volume

132

Issue

9

Start / End Page

1150 / 1152

Location

United States

Related Subject Headings

  • Toxoplasmosis, Ocular
  • Toxoplasma
  • Quinazolines
  • Protein Kinase Inhibitors
  • Ophthalmology & Optometry
  • Middle Aged
  • Lung Neoplasms
  • Humans
  • Food Parasitology
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rao, V., Schneider, E., Proia, A. D., & Fekrat, S. (2014). Development of bilateral acquired toxoplasmic retinochoroiditis during erlotinib therapy. JAMA Ophthalmol, 132(9), 1150–1152. https://doi.org/10.1001/jamaophthalmol.2014.1088
Rao, Veena, Eric Schneider, Alan D. Proia, and Sharon Fekrat. “Development of bilateral acquired toxoplasmic retinochoroiditis during erlotinib therapy.” JAMA Ophthalmol 132, no. 9 (September 2014): 1150–52. https://doi.org/10.1001/jamaophthalmol.2014.1088.
Rao V, Schneider E, Proia AD, Fekrat S. Development of bilateral acquired toxoplasmic retinochoroiditis during erlotinib therapy. JAMA Ophthalmol. 2014 Sep;132(9):1150–2.
Rao, Veena, et al. “Development of bilateral acquired toxoplasmic retinochoroiditis during erlotinib therapy.” JAMA Ophthalmol, vol. 132, no. 9, Sept. 2014, pp. 1150–52. Pubmed, doi:10.1001/jamaophthalmol.2014.1088.
Rao V, Schneider E, Proia AD, Fekrat S. Development of bilateral acquired toxoplasmic retinochoroiditis during erlotinib therapy. JAMA Ophthalmol. 2014 Sep;132(9):1150–1152.

Published In

JAMA Ophthalmol

DOI

10.1001/jamaophthalmol.2014.1088

EISSN

2168-6173

Publication Date

September 2014

Volume

132

Issue

9

Start / End Page

1150 / 1152

Location

United States

Related Subject Headings

  • Toxoplasmosis, Ocular
  • Toxoplasma
  • Quinazolines
  • Protein Kinase Inhibitors
  • Ophthalmology & Optometry
  • Middle Aged
  • Lung Neoplasms
  • Humans
  • Food Parasitology
  • Female